1 |
Kao TC, Wu CH, Yen GC. Bioactivity and potential health benefits of licorice. J Agric Food Chem. 2014. 62: 542-553.
DOI
|
2 |
Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005. 1754: 253 -262.
DOI
|
3 |
Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006. 13: 816 -825.
DOI
|
4 |
Kim SJ, Kim CG, Yun SR, Kim JK, Jun JG. Synthesis of licochalcone analogues with increased anti-inflammatory activity. Bioorg Med Chem Lett. 2014. 24: 181-185.
DOI
|
5 |
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002. 105: 1135-1143.
DOI
|
6 |
O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007. 7: 353-364.
DOI
|
7 |
Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signaling: implications for inflammatory diseases. Nat Rev Immunol. 2009. 9: 778-788.
DOI
|
8 |
Pulverer BJ1, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991. 353: 670-674.
DOI
|
9 |
Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflam-mation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011. 70 Suppl: 109-112.
DOI
|
10 |
Smith AM, Sewell GW, Levine AP, Chew TS, Dunne J, O'Shea NR, Smith PJ, Harrison PJ, Macdonald CM, Bloom SL, Segal AW. Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients. Immunology. 2015. 144: 45-55.
DOI
|
11 |
Agarwal M, Parameswari RP, Vasanthi HR, Das DK. Dynamic action of carotenoids in cardioprotection and maintenance of cardiac health. Molecules. 2012. 17: 4755-4769.
DOI
|
12 |
Arango DG, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014. 8: 319.
|
13 |
Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008. 22: 709-724.
DOI
|
14 |
Baker RG, Hayden MS, Ghosh S. NF-, inflammation, and metabolic disease. Cell Metab. 2011. 13: 11-22.
DOI
|
15 |
Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005. 78: 431-441.
DOI
|
16 |
Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity. 2010. 32: 305-315.
DOI
|
17 |
Chen RH, Juo PC, Curran T, Blenis J. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene. 1996. 12: 1493-1502.
|
18 |
Chun J, Choi RJ, Khan S, Lee DS, Kim YC, Nam YJ, Lee DU, Kim YS. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int Immunopharmacol. 2012. 14: 375-383.
DOI
|
19 |
Di Lorenzo C, Dell'Agli M, Badea M, Dima L, Colombo E, Sangiovanni E, Restani P, Bosisio E. Plant food supplements with anti-inflammatory properties: a systematic review (II). Crit Rev Food Sci Nutr. 2013. 53: 507-516.
DOI
|
20 |
Dinarello CA. A clinical perspective of IL- as the gatekeeper of inflammation. Eur J Immunol. 2011. 41: 1203-1217.
DOI
|
21 |
Gilroy D, De Maeyer R. New insights into the resolution of inflammation. Semin Immunol. 2015. 27: 161-168.
DOI
|
22 |
Guina T, Biasi F, Calfapietra S, Nano M, Poli G. Inflammatory and redox reactions in colorectal carcinogenesis. Ann N Y Acad Sci. 2015. 1340: 95-103.
DOI
|
23 |
Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014. 22: 147-151.
DOI
|
24 |
Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006. 46: 167-192.
DOI
|
25 |
Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene. 2001. 20: 2401-24112.
DOI
|
26 |
Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008. 10: 201.
|
27 |
Snelten CS, Dietz B, Bolton JL. Modulation of estrogen chemical carcinogenesis by botanical supplements used for postmenopausal women's health. Drug Discov Today Dis Mech. 2012. 9: 47-54.
DOI
|
28 |
Wisdom R. AP-1: one switch for many signals. Exp Cell Res. 1999. 253: 180-185.
DOI
|
29 |
Xiao JB, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015. 22: 23-38.
|